Rx only · Injection · Intramuscular
Promethazine Hydrochloride
Brands: Phenergan · Promethazine Hydrochloride
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US21 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.784
Latest avg · Jul 22, 2026
+3%
Since Sep 17, 2025
6
Active US suppliers
76%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
14K
Rx · 2026 Q1
52K
Units dispensed
-47%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 13 | SUPPLYING |
| Henry Schein Inc. | unknown | 3 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Nov 21, 2023SHORTAGEDrug shortage: Promethazine Hydrochloride Injection (Hikma Pharmaceuticals USA, Inc.)
Promethazine Hydrochloride Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy.
Pill